NASDAQ:CERC
Delisted

Cerecor Stock News

etoro logo Buy CERC
*Your capital is at risk
$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022
Kasar Jamhuriyar Nijer ta bayyana matuka bacin ranta dangane da zargin da ake yi kasar suka aikata a yankunan kan iyakar kasar da Mali, inda kasar ta ce a shirye take kungiyoyin kasashen duniya su gu�
Investors who take an interest in Cerecor Inc. (NASDAQ:CERC) should definitely note that the CEO, President...
A yayin da ake ci gaba da zanga zangar nuna kyamar kabilanci bayan kisan gillar da yan sanda Farar Fata su ka yi wa George Floyd bakar fata a Amruka.Kasashen Afrika, sun bukaci hukumar kare hakkin da�

Largest Insider Trades of the Week

03:42pm, Friday, 12'th Jun 2020
Applied Molecular makes the list Continue reading...
Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today the closing of
Veracyte, Inc. (Nasdaq: VCYT) announced today the publication of an independent study showing that the Envisia Genomic Classifier enables physicians to more...

Do Hedge Funds Love Cerecor Inc. (CERC)?

08:18pm, Wednesday, 10'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Cerecor Inc. (NASDAQ:CERC) and determine whether it is a good investment right now. We at Insider Monkey like to exami
Sowell Financial Services LLC bought a new stake in shares of iShares Commodities Select Strategy ETF (NASDAQ:COMT) in the first quarter, according to its most recent Form 13F filing with the Securiti
Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it has ent
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Biohaven Pharmaceutical...
Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it intends

3 Penny Stocks That Could Climb Over 140%

03:09pm, Monday, 08'th Jun 2020
Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to these

3 Penny Stocks That Could Climb Over 140%

01:49pm, Monday, 08'th Jun 2020
Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to these tickers priced for less than $5 apiece. Dividing
Under every scenario below, it is possible for investors to see a positive investment return. It is necessary to follow which variant the company is taking, as
‘Tata Powers performance has been good throughout the year
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE